To determine the clinical relevance and prognostic value of DLC1, we first performed in silico analysis using Gene expression based Outcome for Breast cancer Online (GOBO) tool, which contains clinico-pathological and Affymetrix gene expression data from 1,881 breast cancer patients [19]. This evidence concerns the gene DLC1 and breast cancer.